Position
Chief Executive Officer
Company
Engimmune Therapeutics
BaselBiotechnologyData And AnalyticsHealth CareScience And EngineeringArtificial IntelligenceDescription
Engimmune Therapeutics AG , a Swiss biotech company developing novel T-cell receptor -based therapeutics, today announces the appointment of Dr. Lars Nieba as Chief Executive Officer. Dr
Quick answer
Engimmune Therapeutics Appoints Dr. Lars Nieba as Chief Executive Officer (April 19, 2023). Engimmune Therapeutics is based in Basel, Basel City, Switzerland.
- Who is the new Chief Executive Officer at Engimmune Therapeutics?
- Engimmune Therapeutics named Lars Nieba Chief Executive Officer, announced April 19, 2023.
- What did Engimmune Therapeutics announce on April 19, 2023?
- Engimmune Therapeutics AG , a Swiss biotech company developing novel T-cell receptor -based therapeutics, today announces the appointment of Dr. Lars Nieba as Chief Executive Officer.
- What does Engimmune Therapeutics do?
- Engimmune is an immunotherapy company utilising cutting-edge methods for the development of T-cell receptor (TCR)-based immunotherapies including T cell therapies and biologics.
- Where is Engimmune Therapeutics based?
- Engimmune Therapeutics is based in Basel, Basel City, Switzerland.
- Which similar companies made leadership changes around the same time?
- Emmes (April 3, 2023), MIXMODE (April 24, 2023), Addionics (May 4, 2023) and Quibim (May 26, 2023) also announced leadership changes within 45 days of Engimmune Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Data And Analytics and Science And Engineering
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Emmes Hires Becky Marson as Chief People and Performance Officer (April 3, 2023)
- MixMode Appoints Karen Buffo as Chief Marketing Officer (April 24, 2023)
- Addionics Expands US Leadership Team with the Appointment of Sam Jaffe as Senior Director of Business Development (May 4, 2023)
- Quibim, a company leveraging artificial intelligence to improve cancer diagnostics, makes key move into U.S. by hiring Boston-based chief medical officer (May 26, 2023)
- Fountain Life Promotes Helen Messier, M.D., Ph.D. to Chief Medical Officer (April 18, 2023)
- HARMONY BIOSCIENCES ANNOUNCES JEFFREY M. DAYNO, M.D. APPOINTED PRESIDENT & CHIEF EXECUTIVE OFFICER (April 24, 2023)
Who to call at Engimmune Therapeutics, and when
A new leader at Engimmune Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Engimmune Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Engimmune Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Engimmune Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Engimmune Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Engimmune Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.